Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

61509 1497862462HCLSReviewTaiwanJune2017.pdf
Energy Boardroom

Xtandi approved in Japan for CRPC

24.03.2014 / Scripintelligence

The once-daily therapy, co-developed with Medivation, was filed in the country in May 2013 and approved in the US in August 2012 and in the EU in June 2013 for metastatic CRPC in patients who have previously received docetaxel.

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: